PACELF
Pacifc Programme to Eliminate Lymphatic Filariasis
How you can help Mailing List Contact Us
.
About PacElf
Our Work
Progress
Country Programmes
Annual Reports
Mosquito Newsletter
Related Links
Frequently Asked Questions
Publications
Publications
GA4 Meeting
Home
.

Country Programmes
Samoa Map

Mumu Tutupa


General Information

Capital city
Number of islands
Land area
Language
Ethnicity
GNP per capita
Economy
Apia
9
2,935 sq km
Samoan, English
Polynesian
US$1,020
Agriculture, tourism, manufacturing, remittances, aid
Total population by census (2001)
Population estimated (2000)
Male/Female
Population growth rate
Population density
Life expectancy at birth

174,140
1
69,200
109/100
0.23%
59.3 sq km
69.5
Mortality: Circulatory diseases, respiratory diseases, infectious and parastic diseases.

POPULATION

WEATHER



History of Filariasis Prevalence

Year Study Group Symptoms Prevalence
1923 E&W, Samoa elephantiasis 2.7%
1928 Males elephantiasis 5.6%
Hydrocele 16%
1954 elephantiasis 3.6%
lymphadenitis 15-20%
1995-1996 elephantiasis 2%
There is a long history of MDA campaigns being conducted to control filariasis in Samoa. From 1964 until 1999, eleven different campaigns were held. The first seven using DEC and in 1996 and 1997 a combination of DEC and Ivermectin was used.


PacELF Activities carried out to date:

Blood Survey PACELF Activities in Samoa
Mass drug administration (DEC 6mg/kg + Albendazole 400mg)
Health education
Mass media campaign
Workshops
Vector control
Intestinal parasite survey

Filaria Type Wuchereria bancrofti Diurnally sub-periodic
Mosquito vectors Aedes polynesiensis, Aedes updensis, Ochlerotatus oceanicus, Ochlerotatus samoanus, Ochlerotatus tutuilae
Filariasis latest status Endemic
Operational Staff Filariasis Control, Health Inspector, Public Health Nurse
Partnership JICA (DEC&ICT), GSK (Albendazole), JOCV (Volunteer)


Results of MDAs carried out under PacELF Programme

Year MDA Reported Population

Registered
Population

% Registered

Treated Population

%Treated/
Total

%Treated/
Registered

1999

1st

161298

152022

94.25 145952 90.49 96.01
2000 2nd 161298 95196 59.02 91613 56.80 96.24
2001 3rd 174140 127198 73.04 119100 68.39 93.63
2002 4th 176848 115086 65.08 106561 60.26 92.59
2003 5th 176848 150596 85.16 140855 79.65 93.53

Results of blood surveys carried out under PacELF Programme

Date

Method of Test

Target

Sampling Method

No. of examined

No. of Positives

Positive rate(%)

1999

ICT

27 villages

Convenience

7006

317

4.52

2000

ICT

Sentinel sites (3 villages)

Convenience

676

55

8.14

2000 MF Sentinel sites (3 villages) Convenience 88 7 7.95

2001

ICT

Sentinel sites (4 villages)

Convenience

1392

67

4.81

2001 MF Sentinel sites (4 villages) Convenience 67 10 14.93
2002 ICT Sentinel sites (10 villages) Convenience 2141 96 4.48
2002 MF Sentinel sites (10 villages) Convenience 2265 6 0.26

2003

ICT

Sentinel sites (6 villages)

Convenience

881

14

1.59

2003 MF Sentinel sites (6 villages) Convenience 881 6 0.68
2004 ICT Whole area stratified cluster sample 12719 144 1.1
2004 MF Whole area stratified cluster sample 12719 55 0.4
2005 ICT Sentinel sites (6 villages) Convenience 1259 38 3.02
2005 MF Sentinel sites (6 villages) Convenience 1259 6 0.48

Contact:

Ms Fuatai Maiava
Communicable Disease National Programme Coordinator
Office of the WHO Representative in Samoa
P.O Box 77, Apia, Samoa
Tel/ (685) 23 756 Fax/ (685) 23 765
E-mail: maiavaf@sma.wpro.who.int

Lymphatic Filariasis • Waqaqa • Big Leg • Filariasis • Aoraki Man Te Mata • Rektel a Rekas • Mumu Tutupa • Mwirara • Filariasis Pwuur • Moko Pata • Kinal • Te Fu'aa • Va'e Fua • Eke'Eke • Mumu Tutupa • fe'fee • Va'e Fua • Legi Biki